This suggests that the IL-17-mediated immune response may be associated with long COVID, and it may also indicate that patients have an enhanced IL-17-mediated immune response after psoriasis exacerbation, which may explain psoriasis flare-up as one of the risk factors for long COVID. This evidence concerns the gene IL17A and psoriasis.